Manchin, Braun Address Misleading Marketing of Dangerous Opioids
September 07, 2023
September 07, 2023
WASHINGTON, Sept. 7 -- Sen. Joe Manchin, D-West Virginia, issued the following news release:
Washington, DC--Today, U.S. Senators Joe Manchin (D-WV) and Mike Braun (R-IN) reintroduced the bipartisan FDA Review of Efficacy EERW Double-Blinds (FREED) of Opioids Act, which would require scientific experts to review the controversial enriched enrollment randomized withdrawal (EERW) methodology used to approve new opioids and ensure opioids are only marketed for uses where they are both . . .
Washington, DC--Today, U.S. Senators Joe Manchin (D-WV) and Mike Braun (R-IN) reintroduced the bipartisan FDA Review of Efficacy EERW Double-Blinds (FREED) of Opioids Act, which would require scientific experts to review the controversial enriched enrollment randomized withdrawal (EERW) methodology used to approve new opioids and ensure opioids are only marketed for uses where they are both . . .